Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland

Carole Bandiera; Xiomara Skrabal Ross; Evelina Cardoso; Dorothea Wagner; Chantal Csajka; Ian Olver; Pandora Patterson; Vijayaprakash Suppiah; Kate M. Gunn; Marie Schneider

doi:10.1007/s00520-021-06710-y

Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland

Carole Bandiera, Xiomara Skrabal Ross, Evelina Cardoso, Dorothea Wagner, Chantal Csajka, Ian Olver, Pandora Patterson, Vijayaprakash Suppiah, Kate M. Gunn, Marie Schneider

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Not monitoring adherence to oral anticancer therapies (OAT) can lead to poor clinical outcomes, including premature death as reported by Foulon et al. (Acta Clin Belg 66(2):85–96, 2011) and Greer et al. (Oncologist 21(3):354–76, 2016). Barriers to the implementation of supportive cancer care interventions in medication adherence occur with multiple hospital sites, cancer diagnoses, and numerous healthcare professionals. This commentary describes challenges and strategies from two OAT adherence trials in Australia and Switzerland to assist researchers in the design and implementation of future interprofessional trials.

Original language	English
Pages (from-to)	3655-3659
Number of pages	5
Journal	Supportive Care in Cancer
Volume	30
Issue number	5
DOIs	https://doi.org/10.1007/s00520-021-06710-y
Publication status	Published or Issued - May 2022
Externally published	Yes

Keywords

Clinical trials
Implementation science
Medication adherence
Neoplasms
Oral anticancer therapies, Antineoplastic agents
Patient selection

ASJC Scopus subject areas

Oncology

Access to Document

10.1007/s00520-021-06710-y

Cite this

Bandiera, C., Skrabal Ross, X., Cardoso, E., Wagner, D., Csajka, C., Olver, I., Patterson, P., Suppiah, V., Gunn, K. M., & Schneider, M. (2022). Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland. Supportive Care in Cancer, 30(5), 3655-3659. https://doi.org/10.1007/s00520-021-06710-y

@article{d761e3a8130247b1bc9adb9163543f52,

title = "Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland",

abstract = "Not monitoring adherence to oral anticancer therapies (OAT) can lead to poor clinical outcomes, including premature death as reported by Foulon et al. (Acta Clin Belg 66(2):85–96, 2011) and Greer et al. (Oncologist 21(3):354–76, 2016). Barriers to the implementation of supportive cancer care interventions in medication adherence occur with multiple hospital sites, cancer diagnoses, and numerous healthcare professionals. This commentary describes challenges and strategies from two OAT adherence trials in Australia and Switzerland to assist researchers in the design and implementation of future interprofessional trials.",

keywords = "Clinical trials, Implementation science, Medication adherence, Neoplasms, Oral anticancer therapies, Antineoplastic agents, Patient selection",

author = "Carole Bandiera and {Skrabal Ross}, Xiomara and Evelina Cardoso and Dorothea Wagner and Chantal Csajka and Ian Olver and Pandora Patterson and Vijayaprakash Suppiah and Gunn, {Kate M.} and Marie Schneider",

note = "Funding Information: Funding for the Australian study was supported by the Cancer Research Institute, University of South Australia. The Swiss study is supported since April 2017 by the Swiss Cancer Research foundation, grant n° HSR-4077-11-2016. Publisher Copyright: {\textcopyright} 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.",

year = "2022",

month = may,

doi = "10.1007/s00520-021-06710-y",

language = "English",

volume = "30",

pages = "3655--3659",

journal = "Supportive Care in Cancer",

issn = "0941-4355",

publisher = "Springer Verlag",

number = "5",

}

Bandiera, C, Skrabal Ross, X, Cardoso, E, Wagner, D, Csajka, C, Olver, I, Patterson, P, Suppiah, V, Gunn, KM & Schneider, M 2022, 'Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland', Supportive Care in Cancer, vol. 30, no. 5, pp. 3655-3659. https://doi.org/10.1007/s00520-021-06710-y

Interventions to support adherence to oral anticancer therapies : research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland. / Bandiera, Carole; Skrabal Ross, Xiomara; Cardoso, Evelina et al.

In: Supportive Care in Cancer, Vol. 30, No. 5, 05.2022, p. 3655-3659.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Interventions to support adherence to oral anticancer therapies

T2 - research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland

AU - Bandiera, Carole

AU - Skrabal Ross, Xiomara

AU - Cardoso, Evelina

AU - Wagner, Dorothea

AU - Csajka, Chantal

AU - Olver, Ian

AU - Patterson, Pandora

AU - Suppiah, Vijayaprakash

AU - Gunn, Kate M.

AU - Schneider, Marie

N1 - Funding Information: Funding for the Australian study was supported by the Cancer Research Institute, University of South Australia. The Swiss study is supported since April 2017 by the Swiss Cancer Research foundation, grant n° HSR-4077-11-2016. Publisher Copyright: © 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

PY - 2022/5

Y1 - 2022/5

N2 - Not monitoring adherence to oral anticancer therapies (OAT) can lead to poor clinical outcomes, including premature death as reported by Foulon et al. (Acta Clin Belg 66(2):85–96, 2011) and Greer et al. (Oncologist 21(3):354–76, 2016). Barriers to the implementation of supportive cancer care interventions in medication adherence occur with multiple hospital sites, cancer diagnoses, and numerous healthcare professionals. This commentary describes challenges and strategies from two OAT adherence trials in Australia and Switzerland to assist researchers in the design and implementation of future interprofessional trials.

AB - Not monitoring adherence to oral anticancer therapies (OAT) can lead to poor clinical outcomes, including premature death as reported by Foulon et al. (Acta Clin Belg 66(2):85–96, 2011) and Greer et al. (Oncologist 21(3):354–76, 2016). Barriers to the implementation of supportive cancer care interventions in medication adherence occur with multiple hospital sites, cancer diagnoses, and numerous healthcare professionals. This commentary describes challenges and strategies from two OAT adherence trials in Australia and Switzerland to assist researchers in the design and implementation of future interprofessional trials.

KW - Clinical trials

KW - Implementation science

KW - Medication adherence

KW - Neoplasms

KW - Oral anticancer therapies, Antineoplastic agents

KW - Patient selection

UR - http://www.scopus.com/inward/record.url?scp=85122366430&partnerID=8YFLogxK

U2 - 10.1007/s00520-021-06710-y

DO - 10.1007/s00520-021-06710-y

M3 - Comment/debate

C2 - 34993650

AN - SCOPUS:85122366430

VL - 30

SP - 3655

EP - 3659

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 5

ER -

Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this